Birgit Weynand

This study shows 4'-fluorouridine inhibits Oropouche virus replication in vitro and in animal models, with no resistant variants observed.

This study shows that combining remdesivir and ribavirin significantly reduces HPIV-3 infection in cell cultures and mice, with minimal lung pathology.

This study shows that antigenic imprinting limits neutralizing antibody responses to new SARS-CoV-2 variants in hamsters, suggesting challenges for vaccine efficacy against emerging subvariants.

The paper describes the development of a broadly neutralizing antibody, XVR011, effective against SARS-CoV-2 and its variants in animal models.

This paper develops a single-dose YF17D-vectored SARS-CoV-2 vaccine candidate that induces neutralizing antibodies and protects against infection in hamsters.